298202-25-2
中文名称
298202-25-2
CAS
298202-25-2
分子式
C101H164N24O28S
分子量
2194.59
更新日期
2024/05/21 11:25:56
298202-25-2 结构式
基本信息
英文别名
IRBP (1-20), humanL-Aspartic acid, glycyl-L-prolyl-L-threonyl-L-histidyl-L-leucyl-L-phenylalanyl-L-glutaminyl-L-prolyl-L-seryl-L-leucyl-L-valyl-L-leucyl-L-α-aspartyl-L-methionyl-L-alanyl-L-lysyl-L-valyl-L-leucyl-L-leucyl-
IRBP (1-20), human价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2024/04/30 | HY-P1587 | 298202-25-2 IRBP (1-20), human | 298202-25-2 | 1mg | 1000元 |
| 2024/04/30 | HY-P1587 | 298202-25-2 IRBP (1-20), human | 298202-25-2 | 5mg | 3900元 |
| 2024/04/30 | HY-P1587 | 298202-25-2 IRBP (1-20), human | 298202-25-2 | 10mg | 6600元 |
常见问题列表
生物活性
IRBP (1-20), human 包含 H-2b 单倍型的主要表位。IRBP (1-20), human TFA 诱导 H-2b 小鼠实验性自身免疫性葡萄膜视网膜炎 (EAU)。体内研究
IRBP (1-20), human TFA induces EAU.
For determination of proliferative and cytokine responses, lymph node and spleen cells are collected 21 days after immunization and are stimulated in culture with the appropriate antigen. Cells of C57BL/6 mice and 129/J mice immunized with IRBP (1-20), human TFA proliferated in response to the peptide.
| Animal Model: | C57BL/6 (H-2 b b [2] |
| Dosage: | 200, 300 μg |
| Administration: | I.h.; After 21 days |
| Result: | C57BL/6 (H-2 b b) also developed disease, albeit with a lower average score than C57BL/6. |